Back to Search

LARS WAGNER, MD

MD

Pediatric Hematology & Oncology Physician

NPI: 1730244344Individual

Specialties, Licenses & Credentials

Pediatric Hematology & Oncology PhysicianPrimary

Pediatrics — Pediatric Hematology-Oncology

Code: 2080P0207X

32169(KY)

Research & Publications (20)

Risedronate reduces intracortical porosity in women with osteoporosis.
PMID 19580469·J Bone Miner Res·2010
2-rct
Cognitive adaptability as a moderator of expressive writing effects in an HIV sample.
PMID 18607714·AIDS Behav·2010
2-rct
Nurses' perceptions of safety culture in long-term care settings.
PMID 19538703·J Nurs Scholarsh·2009
8-other
TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.
PMID 19564573·J Leukoc Biol·2009
7-preclinical
ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs.
PMID 19386591·J Biol Chem·2009
7-preclinical
Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
PMID 19501205·Vaccine·2009
4-observational
Updated prevalence estimates of multiple sclerosis in Texas, 1998 to 2003.
PMID 19492265·Tex Med·2009
4-observational
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
PMID 19560002·J Vasc Interv Radiol·2009
8-other
A kinetic model of the inositol trisphosphate receptor based on single-channel data.
PMID 19450477·Biophys J·2009
7-preclinical
Interrogation: our professional body forbids involvement.
PMID 19553972·Nature·2009
8-other
Inattention, hyperactivity-impulsivity, academic skills and psychopathology in boys with and without haemophilia.
PMID 19298375·Haemophilia·2009
8-other
Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody.
PMID 19342084·J Allergy Clin Immunol·2009
5-case
Angiogenic factors in plasma of brain tumour patients.
PMID 19331229·Anticancer Res·2009
8-other
Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions.
PMID 19327106·Clin Chem Lab Med·2009
7-preclinical
Quality improvement guidelines for recording patient radiation dose in the medical record.
PMID 19560000·J Vasc Interv Radiol·2009
8-other
New therapeutic targets for the treatment of high-risk neuroblastoma.
PMID 19277986·J Cell Biochem·2009
6-review
Evaluating the dimensionality of perceived cognitive function.
PMID 19500722·J Pain Symptom Manage·2009
8-other
A road map to health reform.
PMID 19226870·Provider·2009
8-other
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
PMID 19171709·J Clin Oncol·2009
3-trial
Protein kinase A increases type-2 inositol 1,4,5-trisphosphate receptor activity by phosphorylation of serine 937.
PMID 19608738·J Biol Chem·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
KENTUCKY CLINIC OFC J-457, 740 S. LIMESTONE
LEXINGTON, KY 40536

Location

Practice Location

KENTUCKY CLINIC OFC J-457, LEXINGTON, KY
(859) 218-0931

Quick Facts

NPI
1730244344
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile